Kloppenburg M, Berenbaum F. Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthr Cartil England. 2020;28:242–8.
Grässel S, Muschter D. Recent advances in the treatment of osteoarthritis. F1000Res. 2020 May 4;9:F1000 Faculty Rev-325. https://doi.org/10.12688/f1000research.22115.1. PMID: 32419923; PMCID: PMC7199286.
Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020;29–30:100587. https://doi.org/10.1016/j.eclinm.2020.100587.
Aweid O, Haider Z, Saed A, Kalairajah Y. Treatment modalities for hip and knee osteoarthritis: a systematic review of safety. J Orthop Surg. 2018;26:2309499018808669.
Di Nicola V. Degenerative osteoarthritis a reversible chronic disease. Regen Ther. 2020 Aug 15;15:149–60. https://doi.org/10.1016/j.reth.2020.07.007. PMID: 33426213; PMCID: PMC7770340.
Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis. 2011;14:211–5.
Pers Y-M, Rackwitz L, Ferreira R, Pullig O, Delfour C, Barry F, et al. Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Transl Med. 2016;5:847–56.
Prodromos C, Finkle S, Rumschlag T, Lotus J. Autologous Mesenchymal Stem Cell Treatment is Consistently Effective for the Treatment of Knee Osteoarthritis: The Results of a Systematic Review of Treatment and Comparison to a Placebo Group. Medicines (Basel). 2020 Jul 24;7(8):42. https://doi.org/10.3390/medicines7080042. PMID: 32722216; PMCID: PMC7459966.
Jo CH, Lee YG, Shin WH, Kim H, Chai JW, Jeong EC, et al. Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 2014;32:1254–66.
Wang AT, Feng Y, Jia HH, Zhao M, Yu H. Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: a concise review. World J Stem Cells. 2019;11:222–35.
Saeedi P, Halabian R, Fooladi AAI. A revealing review of mesenchymal stem cells therapy, clinical perspectives and modification strategies. Stem Cell Investig. 2019;6:34.
Vega A, Martín-Ferrero MA, Del Canto F, Alberca M, García V, Munar A, et al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation United States. 2015;99:1681–90.
Song Y, Du H, Dai C, Zhang L, Li S, Hunter DJ, et al. Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections. Regen Med England. 2018;13:295–307.
Francis SL, Duchi S, Onofrillo C, Di Bella C, Choong PFM. Adipose-derived mesenchymal stem cells in the use of cartilage tissue engineering: the need for a rapid isolation procedure. Stem Cells Int. 2018;2018:8947548. https://doi.org/10.1155/2018/8947548. Zhang J, editor; Hindawi.
Loo SJQ, Wong NK. Advantages and challenges of stem cell therapy for osteoarthritis (Review). Biomed Rep. 2021 Aug;15(2):67. https://doi.org/10.3892/br.2021.1443. Epub 2021 Jun 10. PMID: 34155451; PMCID: PMC8212446.
Ha CW, Park YB, Kim SH, Lee HJ. Intra-articular mesenchymal stem cells in osteoarthritis of the knee: a systematic review of clinical outcomes and evidence of cartilage repair. Arthrosc J Arthrosc Relat Surg. 2019;35:277–88. https://doi.org/10.1016/j.arthro.2018.07.028. Arthroscopy Association of North America.
Koh YG, Jo SB, Kwon OR, Suh DS, Lee SW, Park SH, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthrosc J Arthrosc Relat Surg. 2013;29:748–55. https://doi.org/10.1016/j.arthro.2012.11.017. Arthroscopy Association of North America.
Koh Y-G, Choi Y-J. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee Netherlands. 2012;19:902–7.
Kim YS, Koh YG. Comparative matched-pair analysis of open-wedge high tibial osteotomy with versus without an injection of adipose-derived mesenchymal stem cells for varus knee osteoarthritis: clinical and second-look arthroscopic results. Am J Sports Med. 2018;46:2669–77.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339:332–6. https://doi.org/10.1136/bmj.b2535.
Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Assessing risk of bias in a randomized trial. In: Cochrane handbook for systematic reviews of interventions. John Wiley & Sons, Ltd; 2019. p. 205–28.
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). https://www.prisma-statement.org//.
•• Tong W, Zhang X, Zhang Q, Fang J, Liu Y, Shao Z, et al. Multiple umbilical cord–derived MSCs administrations attenuate rat osteoarthritis progression via preserving articular cartilage superficial layer cells and inhibiting synovitis. J Orthop Transl. 2020;23:21–8. https://doi.org/10.1016/j.jot.2020.03.007. Elsevier Ltd. This study provides thorough explanation how Umbilical Cord-Mesenchymal Stem Cell could mobilize superficial layer cell (SFC) to injured sites in knee OA to initiate the early repair process and increase SFC proliferation.
Perry J, McCarthy HS, Bou-Gharios G, van’t Hof R, Milner PI, Mennan C, et al. Injected human umbilical cord-derived mesenchymal stromal cells do not appear to elicit an inflammatory response in a murine model of osteoarthritis. Osteoarthr Cartil Open. 2020;2:100044. https://doi.org/10.1016/j.ocarto.2020.100044. Elsevier Ltd.
Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, et al. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I/II trial. Stem Cells Transl Med. 2019;8:215–24.
Dilogo IH, Canintika AF, Hanitya AL, Pawitan JA, Liem IK, Pandelaki J. Umbilical cord-derived mesenchymal stem cells for treating osteoarthritis of the knee: a single-arm, open-label study. Eur J Orthop Surg Traumatol. 2020;30:799–807. https://doi.org/10.1007/s00590-020-02630-5. Springer Paris.
Fiolin J, Dilogo I, Lubis A, Pawitan J, Liem I, Pandelaki J, et al. Functional and radiological comparison of umbilical cord mesenchymal stem cells, somatotropin, and hyaluronic acid injection for cartilage repair in early osteoarthritis of the knee: a randomized controlled trial. Orthop J Sport Med. 2020;8:2325967120S0004.
• Ma W, Liu C, Wang S, Xu H, Sun H, Fan X. Efficacy and safety of intra-articular injection of mesenchymal stem cells in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Medicine. 2020;99:e23343. Baltimore. This study provides a thorough explanation and supporting data that MSC injection is safe with no serious adverse event in clinical application.
Nagamura-Inoue T. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World J Stem Cells. 2014;6:195.
Zhang R, Ma J, Han J, Zhang W, Ma J. Mesenchymal stem cell related therapies for cartilage lesions and osteoarthritis. Am J Transl Res. 2019 Oct 15;11(10):6275–89. PMID: 31737182; PMCID: PMC6834499.
• Lee BC, Kang KS. Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application. Stem Cell Res Ther. 2020;11:1–10. This study provides thorough explanation that UC-MSC possess paracrine and immunomodulatory properties through the secretion of cytokines and growth factors that alter the microenvironment of the knee joint, stimulating local growth and suppressing immunological responses.
Kozhemyakina E, Zhang M, Ionescu A, Ayturk UM, Ono N, Kobayashi A, et al. Identification of a Prg4-expressing articular cartilage progenitor cell population in mice. Arthritis Rheumatol. 2015;67:1261–73. Hoboken, NJ.
Li Z, Huang Z, Bai L. Cell interplay in osteoarthritis. Front Cell Dev Biol. 2021;9:1–18.
Kim YS, Choi YJ, Lee SW, Kwon OR, Suh DS, Heo DB, et al. Assessment of clinical and MRI outcomes after mesenchymal stem cell implantation in patients with knee osteoarthritis: a prospective study. Osteoarthr Cartil. 2016;24:237–45. https://doi.org/10.1016/j.joca.2015.08.009. Elsevier Ltd.
Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthr Cartil. 2007;15:1061–9.
Vincent TL, Williams RO, Maciewicz R, Silman A, Garside P. Mapping pathogenesis of arthritis through small animal models. Rheumatology. 2012;51:1931–41. Oxford, England.
Koh YG, Kwon OR, Kim YS, Choi YJ. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthrosc J Arthrosc Relat Surg. 2014;30:1453–60. https://doi.org/10.1016/j.arthro.2014.05.036. Arthroscopy Association of North America.
Pan F, Jones G. Clinical perspective on pain and pain phenotypes in osteoarthritis. Curr Rheumatol Rep. 2018;20:1–22.
Martínez-Moreno D, Jiménez G, Gálvez-Martín P, Rus G, Marchal JA. Cartilage biomechanics: a key factor for osteoarthritis regenerative medicine. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1067–75. https://doi.org/10.1016/j.bbadis.2019.03.011. Elsevier.
Kaukinen P, Podlipská J, Guermazi A, Niinimäki J, Lehenkari P, Roemer FW, et al. Associations between MRI-defined structural pathology and generalized and localized knee pain – the Oulu Knee Osteoarthritis study. Osteoarthr Cartil. 2016;24:1565–76.
Doyle EC, Wragg NM, Wilson SL. Intraarticular injection of bone marrow-derived mesenchymal stem cells enhances regeneration in knee osteoarthritis. Knee Surg Sport Traumatol Arthrosc. 2020;28:3827–42. https://doi.org/10.1007/s00167-020-05859-z. Springer Berlin Heidelberg.
Comments (0)